跳至主要内容
临床试验/ITMCTR2200006037
ITMCTR2200006037尚未招募4 期

Retrospective cohort study of Huashi Baidu granules in the treatment of mild COVID-19

Jiujiang Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • It conforms to the mild diagnosis of COVID-19 in the Novel Coronavirus Diagnosis and Treatment Protocol for Pneumonia Infection (Trial Version 9) released by the National Health Commission. The novel Coronavirus nucleic acid test confirmed the mild clinical symptoms, including low fever, slight fatigue, olfactory and gustatory impairment.

排除标准

  • Asymptomatic infected persons; Patients with serious primary diseases of cardio-cerebrovascular, lung, kidney and hematopoietic system; Pregnant or lactating women; History of allergy to prescribed drugs.

研究者

相似试验